Learning objectives

After watching this webinar, participants will:

• understand the unmet need without BNP/NT-proBNP – symptoms and signs of HF have insufficient sensitivity and specificity. Therefore, relevant uncertainty regarding the presence of HF remains without BNP/NT-proBNP;
• know the basic concept of NP pathophysiology – BNP/NT-proBNP are quantitative markers of haemodynamic cardiac stress and, therefore, HF. They quantify the presence and extent of LV systolic dysfunction, LV diastolic dysfunction, valvular dysfunction, and RV dysfunction;
• appreciate the similarities and small differences between BNP and NT-proBNP;
• understand the strong scientific bases for the use of BNP/NT-proBNP in the ED – very high and incremental diagnostic accuracy in diagnostic studies, as well as reduced time to decision and time to discharge in RCTs;
• know the specific rule-out and rule-in cutoffs to be applied in the ED; and 
• understand obesity as the most important confounder and the concept of how to adjust for obesity.

Discover the ACVC Biomarker Talk Series

Read the article: Use of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in the emergency department

Main topic

• Acute Coronary Syndromes - Diagnostic methods

Session information

This webinar is designed for cardiologists specialised in acute cardiovascular care, and also those wishing to update their scientific knowledge on the topic.

During the webinar, you will be encouraged to send your questions by chat and interact with our key opinion leaders who will provide live feedback.

Technical settings

The webinar is available on PC and tablets. The use of a smartphone is not recommended.

To answer the MCQs during the live, you must allow pop-up windows.

A high-speed Internet connection is required (minimum 2 Mbps).